semaglutide & tirzepatide stafford and are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Maintenance therapy on semaglutide or

Adverse Event Reporting Severe Reactions Discontinue use and seek immediate medical attention if you experience severe or unusual side effects

Compounded medications are not reviewed by FDA for safety, effectiveness, or quality before marketing

The medication works to slow the transit of the food in the intestinal tract, creating a feeling of fullness for longer than usual

A separate study by Yale researchers showed that as many as 6.6 million Americans fit these criteria

You should also not use semaglutide with other products that contain the medication or with other GLP-1s

How long does tirzepatide stay in your body after stopping